Improving glycemic and lipid metabolism, controlling blood pressure, and reducing insulin resistance are critical strategies for mitigating the risk of diabetes as a CVD risk factor
Para continuar, ingresa atu cuenta trace-id: 4799e6c2-6cf0-4dc1-a872-baf15dbcbe92 Usamos cookies para mejorar tu experiencia en Mercado Libre
The above results suggest that LALPVYN can effectively protect HepG2 cells from free radical damage
A post hoc power analysis was conducted with G*Power 3.1.9.2 45 ( The power (1- error probability) was calculated by statistical test ANOVA: Repeated measures, within factors at the significance level ( error probability, p = 0.05)
doi: 10.1053/j.gastro.2018.11.082
Acknowledgements This project received funding from Alberta Childrens Hospital Research Institute, the Hotchkiss Brain Institute, the Canadian Institutes of Health Research Foundation Grant (FDN143304) to KY, and the Canadian Foundation for Innovation John Evans Leaders Fund (35763) to ADH